Selenium in the Prevention of Cancer
Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population
  • Phase

  • Study Type

  • Status

    Completed No Results Posted
  • Intervention/Treatment

    high-selenium yeast ...
  • Study Participants

This is a pilot study proceeding an intended international trial.

Hypothesis: Daily intake of selenium supplementation in the form of selenium-enriched yeast tablets will reduce the risk of cancer in healthy individuals.

Objective: The objective of this pilot study was to assess the viability of a full scale randomised trial.

AMENDMENT TO STUDY OBJECTIVE: Mortality analysis during intervention and follow-up as specified in the sections concerning study design and outcome measures.
Study Started
Nov 30
Primary Completion
Jun 30
Study Completion
Jun 30
Last Update
Sep 14

Dietary Supplement SelenoPRECISE selenium-enriched yeast tablet, Pharma Nord Denmark A/S

Selenium enriched-yeast tablet; SelenoPRECISE 100 mcg/d Experimental

Selenium enriched-yeast tablet; SelenoPRECISE 200 mcg/d Experimental

Selenium enriched-yeast tablet; SelenoPRECISE 300 mcg/d Experimental

Yeast tablet Placebo Comparator


Inclusion Criteria:

WHO performance status 0 or 1
No active liver- or kidney disease (Serum ALAT (alanine aminotransferase), alkalic phosphatase, bilirubin, creatinin or urea within 2 S.D of laboratory reference range)
No previous cancer diagnosis
No known HIV-infection
Participant must understand oral and written information
Participant must not use selenium supplementation of above 50 mcg/d
Participant must give written consent prior to inclusion
No Results Posted